• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从口服抗帕金森联合药物治疗快速转换为十二指肠左旋多巴输注。

Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.

作者信息

Meiler Birgit, Andrich Jürgen, Müller Thomas

机构信息

Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum, Germany.

出版信息

Mov Disord. 2008 Jan;23(1):145-6. doi: 10.1002/mds.21800.

DOI:10.1002/mds.21800
PMID:17987653
Abstract

Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option.

摘要

6例患有严重运动并发症的帕金森病(PD)患者,未按照先前推荐的先单独使用左旋多巴进行短暂治疗,而是直接从口服抗帕金森病联合药物治疗方案转换为经鼻十二指肠左旋多巴输注治疗。十二指肠左旋多巴输注在很大程度上减少了运动并发症。我们已经表明,口服左旋多巴单药治疗的前期转换和十二指肠左旋多巴输注的缓慢滴定步骤可以跳过,直接转换为十二指肠左旋多巴是一种安全的选择。

相似文献

1
Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.从口服抗帕金森联合药物治疗快速转换为十二指肠左旋多巴输注。
Mov Disord. 2008 Jan;23(1):145-6. doi: 10.1002/mds.21800.
2
Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease.晚期帕金森病中十二指肠左旋多巴输注单一疗法与口服多种药物联合治疗的比较
Neurology. 2005 Jan 25;64(2):216-23. doi: 10.1212/01.WNL.0000149637.70961.4C.
3
Clinical experience with duodenal infusions of levodopa for the treatment of motor fluctuations in Parkinson's disease.十二指肠输注左旋多巴治疗帕金森病运动波动的临床经验。
Adv Neurol. 1990;53:383-6.
4
Duodenal levodopa infusion for advanced Parkinson's disease: 12-month treatment outcome.十二指肠左旋多巴输注治疗晚期帕金森病:12个月治疗结果
Mov Disord. 2007 Jun 15;22(8):1145-9. doi: 10.1002/mds.21500.
5
Comparison of apomorphine and levodopa infusions in four patients with Parkinson's disease with symptom fluctuations.四名帕金森病症状波动患者中阿扑吗啡与左旋多巴输注的比较。
Acta Neurol Scand. 2009 May;119(5):345-8. doi: 10.1111/j.1600-0404.2008.01104.x. Epub 2008 Sep 25.
6
Duodenal and gastric delivery of levodopa in parkinsonism.
Ann Neurol. 1988 Jun;23(6):589-95. doi: 10.1002/ana.410230611.
7
Continuous duodenal infusions of levodopa: plasma concentrations and motor fluctuations in Parkinson's disease.左旋多巴持续十二指肠输注:帕金森病患者的血浆浓度与运动波动
Clin Neuropharmacol. 1988 Feb;11(1):36-44.
8
Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.左旋多巴“药物假期”联合金刚烷胺输注治疗帕金森病并发症
Mov Disord. 2007 May 15;22(7):1033-6. doi: 10.1002/mds.21448.
9
[Shifting to subcutaneous infusion of apomorphine in advanced Parkinson's disease patients on an out-patient basis: experience and recommendations].[晚期帕金森病患者门诊皮下注射阿扑吗啡的转换:经验与建议]
Neurologia. 2007 Apr;22(3):133-7.
10
Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.十二指肠左旋多巴输注可改善晚期帕金森病患者的生活质量。
Neurodegener Dis. 2008;5(3-4):244-6. doi: 10.1159/000113714. Epub 2008 Mar 6.

引用本文的文献

1
Bound, free, and total L-dopa measurement in plasma of Parkinson's disease patients.帕金森病患者血浆中结合型、游离型和总左旋多巴的测量。
J Neural Transm (Vienna). 2019 Nov;126(11):1417-1420. doi: 10.1007/s00702-019-02057-1. Epub 2019 Aug 8.
2
Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?能否依据现有证据识别出适合左旋多巴/卡比多巴肠凝胶疗法的患者?
eNeurologicalSci. 2017 Jul 2;8:44-53. doi: 10.1016/j.ensci.2017.06.004. eCollection 2017 Sep.
3
Levodopa-carbidopa enteral suspension in advanced Parkinson's disease: clinical evidence and experience.
左旋多巴-卡比多巴肠内悬浮液用于晚期帕金森病:临床证据与经验
Ther Adv Neurol Disord. 2017 Mar;10(3):171-187. doi: 10.1177/1756285616681280. Epub 2016 Dec 1.
4
Catechol-O-methyltransferase inhibitors in Parkinson's disease.儿茶酚-O-甲基转移酶抑制剂在帕金森病中的应用。
Drugs. 2015 Feb;75(2):157-74. doi: 10.1007/s40265-014-0343-0.
5
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care.十二指肠左旋多巴输注治疗晚期帕金森病的效果和安全性:在患者常规护理中的回顾性多中心结局评估。
J Neural Transm (Vienna). 2013 Nov;120(11):1553-8. doi: 10.1007/s00702-013-1026-9. Epub 2013 Apr 18.
6
Elevation of total homocysteine levels in patients with Parkinson's disease treated with duodenal levodopa/carbidopa gel.帕金森病患者经十二指肠给予左旋多巴/卡比多巴凝胶治疗后同型半胱氨酸水平升高。
J Neural Transm (Vienna). 2011 Sep;118(9):1329-33. doi: 10.1007/s00702-011-0614-9. Epub 2011 Feb 27.
7
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?波动性帕金森病的最佳治疗方法是什么:持续药物输送还是丘脑底核深部脑刺激?
J Neural Transm (Vienna). 2011 Jun;118(6):907-14. doi: 10.1007/s00702-010-0555-8. Epub 2010 Dec 25.
8
Levodopa/carbidopa and entacapone in the treatment of Parkinson's disease: efficacy, safety and patient preference.左旋多巴/卡比多巴与恩他卡朋治疗帕金森病:疗效、安全性及患者偏好
Patient Prefer Adherence. 2009 Nov 3;3:51-9. doi: 10.2147/ppa.s4084.